First Shipment Of PAXLOVID, Pfizer’s Novel COVID-19 Oral Treatment Arrives In New Zealand

• PAXLOVIDTM (nirmatrelvir [PF-07321332] is the first oral treatment of its kind; it includes nirmatrelvir, a 3CL (or main) protease inhibitor specifically designed to combat SARS-CoV-2. tablets and ritonavir tablets) • Medsafe gave provisional ...